Back to Browse Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 8

In vitro inhibition of hyaluronidase by sodium copper chlorophyllin complex and chlorophyllin analogs

Authors McCook JP, Dorogi PL, Vasily DB, Cefalo DR

Received 18 April 2015

Accepted for publication 9 June 2015

Published 10 August 2015 Volume 2015:8 Pages 443—448

DOI https://doi.org/10.2147/CCID.S86863

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Dr Jeffrey Weinberg

Video abstract presented by John P McCook.

Views: 419

John P McCook,1 Peter L Dorogi,2 David B Vasily,3 Dustin R Cefalo4

1Discovery Partners, LLC, Frisco, TX, 2CHL Industries, LLC, Easton, PA, 3Aesthetica Cosmetic and Laser Surgery Center, Bethlehem, PA, 4Frontier Scientific, Inc., Logan, UT, USA

Background: Inhibitors of hyaluronidase are potent agents that maintain hyaluronic acid homeostasis and may serve as anti-aging, anti-inflammatory, and anti-microbial agents. Sodium copper chlorophyllin complex is being used therapeutically as a component in anti-aging cosmeceuticals, and has been shown to have anti-hyaluronidase activity. In this study we evaluated various commercial lots of sodium copper chlorophyllin complex to identify the primary small molecule constituents, and to test various sodium copper chlorophyllin complexes and their small molecule analog compounds for hyaluronidase inhibitory activity in vitro. Ascorbate analogs were tested in combination with copper chlorophyllin complexes for potential additive or synergistic activity.
Materials and methods: For hyaluronidase activity assays, dilutions of test materials were evaluated for hydrolytic activity of hyaluronidase by precipitation of non-digested hyaluronate by measuring related turbidity at 595 nm. High-performance liquid chromatography and mass spectroscopy was used to analyze and identify the primary small molecule constituents in various old and new commercial lots of sodium copper chlorophyllin complex.
Results: The most active small molecule component of sodium copper chlorophyllin complex was disodium copper isochlorin e4, followed by oxidized disodium copper isochlorin e4. Sodium copper chlorophyllin complex and copper isochlorin e4 disodium salt had hyaluronidase inhibitory activity down to 10 µg/mL. The oxidized form of copper isochlorin e4 disodium salt had substantial hyaluronidase inhibitory activity at 100 µg/mL but not at 10 µg/mL. Ascorbate derivatives did not enhance the hyaluronidase inhibitory activity of sodium copper chlorophyllin. Copper isochlorin e4 analogs were always the dominant components of the small molecule content of the commercial lots tested; oxidized copper isochlorin e4 was found in increased concentrations in older compared to newer lots tested.
Conclusion: These results support the concept of using the hyaluronidase inhibitory activity of sodium copper chlorophyllin complex to increase the hyaluronic acid level of the dermal extracellular matrix for the improvement of the appearance of aging facial skin.

Keywords: sodium hyaluronate, extracellular matrix, porphyrin, dermal matrix, glycosaminoglycans, chlorophyll derivative

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other article by this author:

Readers of this article also read:

Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid

Lee SY, Huh W, Jung JA, Yoo HM, Ko JW, Kim JR

Drug Design, Development and Therapy 2015, 9:4559-4563

Published Date: 10 August 2015

Sex differences in use of inhalants by elderly patients with asthma

Hirose M, Kondo R, Ban N, Kuwabara K, Shiga M, Horiguchi T

Clinical Interventions in Aging 2015, 10:1305-1310

Published Date: 10 August 2015

Associations between cardiovascular risk factors and psoriasis in Iran

Farshchian M, Ansar A, Sobhan M

Clinical, Cosmetic and Investigational Dermatology 2015, 8:437-442

Published Date: 10 August 2015

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Particle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugs

Rao S, Song Y, Peddie F, Evans AM

International Journal of Nanomedicine 2011, 6:1245-1251

Published Date: 20 June 2011

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010